1. Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling. Issue 6 (December 2018) Authors: Han, Jibo; Ye, Shiju; Zou, Chunpeng; Chen, Taiwei; Wang, Jingying; Li, Jieli; Jiang, Liqin; Xu, Jianjiang; Huang, Weijian; Wang, Yi; Liang, Guang Journal: Hypertension Issue: Volume 72:Issue 6(2018:Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis. Issue 11 (6th September 2022) Authors: Han, Jibo; Dai, Shanshan; Zhong, Lingfeng; Shi, Xiaowen; Fan, Xiaoxi; Zhong, Xin; Lin, Wante; Su, Lan; Lin, Shuang; Han, Bingjiang; Xu, Jianjiang; Hong, Xia; Huang, Weijian; Ye, Bozhi Journal: Hypertension Issue: Volume 79:Issue 11(2022) Page Start: 2505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MD2 Blockage Protects Obesity‐Induced Vascular Remodeling via Activating AMPK/Nrf2. Issue 9 (20th July 2017) Authors: Wang, Lintao; Han, Jibo; Shan, Peiren; You, Shengban; Chen, Xuemei; Jin, Yiyi; Wang, Jingying; Huang, Weijian; Wang, Yi; Liang, Guang Journal: Obesity Issue: Volume 25:Issue 9(2017) Page Start: 1532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation. Issue 31 (30th September 2022) Authors: Luo, Wu; Lin, Ke; Hua, Junyi; Han, Jibo; Zhang, Qiuyan; Chen, Lingfeng; Khan, Zia A.; Wu, Gaojun; Wang, Yi; Liang, Guang Journal: Advanced science Issue: Volume 9:Issue 31(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Schisandrin C targets Keap1 and attenuates oxidative stress by activating Nrf2 pathway in Ang II‐challenged vascular endothelium. (10th January 2019) Authors: Han, Jibo; Shi, Xiaowen; Du, Yao; Shi, Fengjie; Zhang, Bin; Zheng, Zhanxiong; Xu, Jianjiang; Jiang, Liqin Journal: Phytotherapy research Issue: Volume 33:Number 3(2019) Page Start: 779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes. Issue 4 (1st February 2023) Authors: Ye, Bozhi; Zhou, Hao; Chen, Yanghao; Luo, Wu; Lin, Wante; Zhao, Ying; Han, Jibo; Han, Xue; Huang, Weijian; Wu, Gaojun; Wang, Xu; Liang, Guang Journal: Circulation research Issue: Volume 132:Issue 4(2023) Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Wogonin Alleviates Cisplatin-induced Cardiotoxicity in Mice Via Inhibiting Gasdermin D-mediated Pyroptosis. Issue 4 (16th October 2021) Authors: Xu, Jiajun; Zhang, Bin; Chu, Zhenliang; Jiang, Fenfen; Han, Jibo Journal: Journal of cardiovascular pharmacology Issue: Volume 78:Issue 4(2021) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Wogonin Alleviates Cisplatin-induced Cardiotoxicity in Mice Via Inhibiting Gasdermin D-mediated Pyroptosis. Issue 4 (October 2021) Authors: Xu, Jiajun; Zhang, Bin; Chu, Zhenliang; Jiang, Fenfen; Han, Jibo Journal: Journal of cardiovascular pharmacology Issue: Volume 78:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses. (1st July 2021) Authors: Shi, Xiaowen; Zhang, Bin; Chu, Zhenliang; Han, Bingjiang; Zhang, Xueping; Huang, Ping; Han, Jibo Other Names: Yu Hangang Academic Editor. Journal: Cardiovascular therapeutics Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗